What Researchers Did
Researchers reviewed the current literature on the use of hyperbaric oxygen therapy (HBOT) as an adjunct treatment for necrotizing soft tissue infections.
What They Found
They found that hyperbaric oxygen therapy (HBOT) significantly improves the effectiveness of multidisciplinary treatment for necrotizing soft tissue infections. HBOT aids wound healing through bactericidal and bacteriostatic effects and by increasing oxygen supply to cellular levels, optimizing oxygen-dependent metabolic processes.
What This Means for Canadian Patients
Canadian patients with necrotizing soft tissue infections could benefit from hyperbaric oxygen therapy (HBOT) when available as part of a comprehensive treatment plan. Utilizing HBOT alongside surgery, critical care, and antibiotics may improve outcomes and wound healing for these severe infections.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature without presenting new empirical data or addressing potential biases in the reviewed studies.